Epigenetic mutational landscape in breast cancer: role of the histone methyltransferase gene KMT2D in triple negative tumors
S. Morcillo Garcia, M. d. M. Noblejas Lopez, C. Nieto Jimenez, J. Perez Pena, M. Nuncia Cantarero, B. Györffy, E. Amir, A. Pandiella, E. M. Galan Moya, A. Ocana
The paper identifies KMT2D mutations in triple negative breast cancer linked to poor prognosis and confirms its prognostic value through transcriptomic analysis.
bioRxiv · Dec 3, 2018Cancer Biology